| __timestamp | Intra-Cellular Therapies, Inc. | Ionis Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 21226345 | 241751000 |
| Thursday, January 1, 2015 | 87718074 | 322292000 |
| Friday, January 1, 2016 | 93831530 | 344320000 |
| Sunday, January 1, 2017 | 79419009 | 374644000 |
| Monday, January 1, 2018 | 132166913 | 414604000 |
| Tuesday, January 1, 2019 | 89124838 | 466000000 |
| Wednesday, January 1, 2020 | 65782137 | 535000000 |
| Friday, January 1, 2021 | 88845513 | 643000000 |
| Saturday, January 1, 2022 | 134715000 | 833000000 |
| Sunday, January 1, 2023 | 180142000 | 899625000 |
| Monday, January 1, 2024 | 901530000 |
Data in motion
In the ever-evolving world of biotechnology, research and development (R&D) investments are the lifeblood of innovation. Over the past decade, Intra-Cellular Therapies, Inc. and Ionis Pharmaceuticals, Inc. have demonstrated a steadfast commitment to advancing medical science.
From 2014 to 2023, Ionis Pharmaceuticals consistently outpaced Intra-Cellular Therapies in R&D spending, with an average annual investment nearly five times greater. Notably, Ionis's R&D expenses surged by approximately 272% from 2014 to 2023, reflecting its aggressive pursuit of groundbreaking therapies. Meanwhile, Intra-Cellular Therapies exhibited a remarkable 748% increase in R&D spending over the same period, underscoring its dedication to innovation despite a smaller budget.
These investments highlight the critical role of R&D in driving biotech advancements, promising a future of transformative treatments and therapies.
Research and Development Investment: Genmab A/S vs Intra-Cellular Therapies, Inc.
R&D Spending Showdown: Intra-Cellular Therapies, Inc. vs Opthea Limited
R&D Spending Showdown: Intra-Cellular Therapies, Inc. vs Apellis Pharmaceuticals, Inc.
Intra-Cellular Therapies, Inc. or Celldex Therapeutics, Inc.: Who Invests More in Innovation?
Who Prioritizes Innovation? R&D Spending Compared for BioMarin Pharmaceutical Inc. and Ionis Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Ascendis Pharma A/S and Ionis Pharmaceuticals, Inc.
Ionis Pharmaceuticals, Inc. or Verona Pharma plc: Who Invests More in Innovation?
Research and Development: Comparing Key Metrics for Ionis Pharmaceuticals, Inc. and Amicus Therapeutics, Inc.
R&D Spending Showdown: Ionis Pharmaceuticals, Inc. vs MorphoSys AG
Research and Development Investment: Ionis Pharmaceuticals, Inc. vs Taro Pharmaceutical Industries Ltd.
Comparing Innovation Spending: Ionis Pharmaceuticals, Inc. and Novavax, Inc.
Research and Development Expenses Breakdown: Ionis Pharmaceuticals, Inc. vs Xencor, Inc.